Overall survival outcomes with sipuleucel-T (Sip-T) among Black men with metastatic castrate-resistant prostate cancer (mCRPC) also treated with androgen receptor pathway inhibitors (ARPI).

Authors: Patrick O'Shea, Matthew Labriola, Lauren Howard, Susan Halabi, Mark T. Fleming, Elisabeth I. Heath, Ronald Tutrone, Brian E. Lewis, Michael Sandon Humeniuk, Michael Roger Harrison, Julie Kephart, Julia Hurrelbrink, Julia Rasmussen, Kellie Shobe, Monika Anand, Marco Reyes-Martinez, Steven R. Patierno, Jennifer A. Freedman, Andrew J. Armstrong, Daniel J. George

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17064

Source: Full article

---

Abstract

e17064